sphingotec GmbH

Neuendorfstraße 15A
Hennigsdorf
16761
Germany

Show jobs for this employer

About sphingotec GmbH

sphingotec GmbH (Hennigsdorf, Germany) develops innovative biomarkers for prediction, diagnosis and therapy monitoring of AKI, congestive heart failure and septic shock. The company, founded by Dr. Andreas Bergmann in 2002, has also in its portfolio biomarkers which can predicts risks of obesity, breast cancer and cardiovascular diseases.

YEAR FOUNDED:

2002

LEADERSHIP:

Founder and CEO: Andreas Bergmann

2 articles with sphingotec GmbH